Literature DB >> 25889621

A case of marginal zone B cell lymphoma mimicking IgG4-related dacryoadenitis and sialoadenitis.

Miho Ohta1, Masafumi Moriyama2, Yuichi Goto3, Shintaro Kawano4, Akihiko Tanaka5, Takashi Maehara6, Sachiko Furukawa7, Jun-Nosuke Hayashida8, Tamotsu Kiyoshima9, Mayumi Shimizu10, Yojiro Arinobu11, Seiji Nakamura12.   

Abstract

BACKGROUND: IgG4-related dacryoadenitis and sialoadenitis (IgG4-DS), so-called Mikulicz's disease, is characterized by elevated serum IgG4 and infiltration of IgG4-positive plasma cells in glandular tissues. Recently, several studies reported both malignant lymphoma developed on the background of IgG4-associated conditions and IgG4-producing malignant lymphoma (non-IgG4-related disease). CASE
PRESENTATION: We report on the case of a 70-year-old man who was strongly suspected IgG4-DS because of high serum IgG4 concentration (215 mg/dl) and bilateral swelling of parotid and submandibular glands. Biopsies of cervical lymph node and a portion of submandibular gland were performed. These histopathological findings subsequently confirmed a diagnosis of marginal zone B cell lymphoma.
CONCLUSION: Differential diagnosis of IgG4-DS is necessary from other disorders, including Sjögren's syndrome, sarcoidosis, Castleman's disease, Wegener's granulomatosis, lymphoma, and cancer. We suggest that biopsy of swollen lesions is important for a definitive diagnosis of IgG4-DS and discuss the mechanism of development in this case.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25889621      PMCID: PMC4350294          DOI: 10.1186/s12957-015-0459-z

Source DB:  PubMed          Journal:  World J Surg Oncol        ISSN: 1477-7819            Impact factor:   2.754


Background

IgG4-related dacryoadenitis and sialoadenitis (IgG4-DS), also known as Mikulicz’s disease (MD), is a unique condition characterized by enlargement of the lacrimal and salivary glands caused by infiltration of lymphocytes. IgG4-DS has been considered a subtype of Sjögren’s syndrome (SS) because of certain histopathological similarities, particularly lymphocytic infiltration [1]. However, IgG4-DS patients show elevated serum levels of IgG4 and infiltrating IgG4-positive plasma cells in the glandular tissues [2,3]. Similar findings have also been identified in other diseases such as autoimmune pancreatitis [4], interstitial pneumonia [5], retroperitoneal fibrosis [6], and sclerosing cholangitis [7], and these diseases are now referred to as ‘IgG4-related disease (IgG4-RD)’ [8]. IgG4-DS is now diagnosed by both ‘Comprehensive diagnostic criteria for IgG4-related disease (2011)’ and ‘Diagnostic criteria for IgG4-related Mikulicz’s disease D’ approved by the Japanese Society for Sjögren’s syndrome [9]. However, it is important to differentiate IgG4-RD from malignant tumors (such as cancer, lymphoma) and similar diseases (such as SS, primary sclerosing cholangitis, Castleman’s disease, secondary retroperitoneal fibrosis, Wegener’s granulomatosis, sarcoidosis, Churg-Strauss syndrome) by histopathological examination of local lesion. We reported the first case of IgG4-producing marginal zone B cell lymphoma (MZL) in salivary glands mimicking IgG4-DS.

Case presentation

A 70-year-old man was referred to our institution with bilateral continuous painless swelling of the parotid glands (PGs) and submandibular glands (SMGs) in March 2013. He had previously attended another hospital with chief complaints of dry mouth and bilateral swelling of SMGs, which were diagnosed as chronic sialoadenitis by computed tomography (CT) in January 2013. However, he did not receive any treatment at that time and ignored the swelling. He had no medical history of allergic diseases such as bronchial asthma, atopic dermatitis, or allergic rhinitis. Physical findings showed no fever (body temperature, 36.6°C), a blood pressure of 124/68 mmHg, a pulse rate of 64 beats per min, and arterial oxygen saturation of 98% in room air. He had a dry mouth and stomatitis with reduced unstimulated salivary flow rate (0.9 ml/15 min). Bilateral PGs, SMGs, and sublingual glands were elastic, hard, and swollen, but not painful. Several cervical lymph nodes were enlarged. F-18 fluorodeoxyglucose positron emission tomography (FDG-PET) demonstrated abnormal multiple accumulations in the SMGs (SUVmax, 4.63) and in several systemic lymph nodes (SUVmax, 3.23–4.12) (Figure 1A). CT and magnetic resonance imaging showed remarkable swelling of bilateral PGs, SMGs, and generalized lymph nodes, including in the neck (Figure 1b). On ultrasonograms, SMGs showed bilateral nodal hypoechoic areas with high vascularization, whereas PGs showed normal or slight change (Figure 1C).
Figure 1

Imaging findings before treatment. (A) Fluorodeoxyglucose positron emission tomography (FDG-PET) indicating abnormal multiple accumulations in the submandibular glands (SMGs) (white arrowheads) and in several systemic lymph nodes (black arrowheads). (B) Computed tomography (CT) findings indicating swelling of the parotid glands (PGs) (white arrowheads), SMGs (white arrowheads), and generalized lymph nodes (LNs) (white arrows). (C) Sonographic images indicating bilateral nodal hypoechoic areas in the SMGs.

Imaging findings before treatment. (A) Fluorodeoxyglucose positron emission tomography (FDG-PET) indicating abnormal multiple accumulations in the submandibular glands (SMGs) (white arrowheads) and in several systemic lymph nodes (black arrowheads). (B) Computed tomography (CT) findings indicating swelling of the parotid glands (PGs) (white arrowheads), SMGs (white arrowheads), and generalized lymph nodes (LNs) (white arrows). (C) Sonographic images indicating bilateral nodal hypoechoic areas in the SMGs. Laboratory findings are indicated in Table 1. He had an increased erythrocyte sedimentation rate (15 mm/h), hemoglobin concentration of 12.6 g/dl, white blood cell count of 4,680/mm3 (neutrophils 40.7%, lymphocytes 49.8%, monocytes 8.5%, eosinophils 0.4%, basophils 0.6%), and platelet count of 12.6 × 104/mm3. Serum chemistry data were all within normal limits. His C-reactive protein concentration was 0.07 mg/dl. Immunological tests were negative for anti-nuclear antibody, anti-SS-A antibody, and rheumatoid factor. Serum levels of IgG, IgA, IgM, and IgE were within normal limits (1,177 mg/dl, 179 mg/ml, 91 mg/dl, and 15 IU/ml, respectively), but his serum IgG4 concentration was elevated (215 mg/dl). The proportion of total IgG molecules that were subclass IgG4 was 18%. The serum soluble interelukin-2 receptor (sIL-2R) concentration was abnormally high (1,566.2 U/ml).
Table 1

Laboratory data before and after treatment

Treatment Reference range
Before After
WBC (/mm3)4,6803,6203,500–9,000
Neutrophils (%)40.7-40.0–70.0
Lymphocytes (%)49.837.018.0–53.0
Monocytes (%)8.5 12.5 2.0–12.0
Eosinophils (%)0.42.51.0–4.0
Basophils (%)0.6 3.0 0.0–1.0
Hemoglobin (g/dl) 12.6 13.9 14.0–18.0
Palate (104/mm3) 12.6 16.614.0–44.0
ESR (mm/h) 12 -2–10
Total protein (g/dl) 6.6 6.5 6.7–8.3
Albumin (g/dl)4.04.34.0–5.0
LDH (U/L)182177119–229
CRP (mg/dl)0.070.02<0.10
IgG (mg/dl)1,177993872–1,815
IgG4 (mg/dl) 215 195 4.8–105
IgA (mg/dl)17919695–405
IgM (mg/dl)916631–190
IgE (mg/dl)15-<240
sIL-2R (U/ml) 1,566.2 752.0 206.0–713.0

WBC white blood cell, ESR erythrocyte sedimentation rate, CRP C-reactive protein, sIL-2R soluble interleukin-2 receptor. Bold and italicized numbers indicate abnormal values.

Laboratory data before and after treatment WBC white blood cell, ESR erythrocyte sedimentation rate, CRP C-reactive protein, sIL-2R soluble interleukin-2 receptor. Bold and italicized numbers indicate abnormal values. IgG4-DS was initially suspected because of the enlarged glandular tissues and high serum IgG4 concentration. Open biopsies of the cervical lymph node and a portion of the left SMG were therefore performed for definitive diagnosis. Histologically, all sections showed severe lymphoplasmacytic infiltration with hyperplastic lymphoid follicles, so-called follicular colonization. Furthermore, the plasmacytoid cells showed nuclear pleomorphism. Immunohistochemical staining showed mild infiltration of IgG4-positive plasma cells (IgG4-positive/IgG-positive plasma cell ratio, 10%) and monotypic predominance of kappa-light chain. The infiltrating lymphocytes were positive for B cell markers (CD20 and CD79a) and bcl-2, but negative for T-cell markers (CD3, CD5, CD8, and CD45RO), CD10 and cyclinD1 (Figure 2).
Figure 2

Histological findings in submandibular glands. (A) Severe lymphoplasmacytic infiltration with hyperplastic lymphoid follicles, so-called ‘follicular colonization’ (white arrowheads). (B) mild infiltration of IgG4-positive plasma cells (IgG4-positive/IgG-positive plasma cell ratio, 10%). (C) Monotypic predominance of kappa-light chain. (D) Infiltrating lymphocytes were positive for B cell markers (CD79a), but negative for T-cell markers (CD3).

Histological findings in submandibular glands. (A) Severe lymphoplasmacytic infiltration with hyperplastic lymphoid follicles, so-called ‘follicular colonization’ (white arrowheads). (B) mild infiltration of IgG4-positive plasma cells (IgG4-positive/IgG-positive plasma cell ratio, 10%). (C) Monotypic predominance of kappa-light chain. (D) Infiltrating lymphocytes were positive for B cell markers (CD79a), but negative for T-cell markers (CD3). These histopathological findings and clinical features confirmed a diagnosis of MZL. The patient was treated with 600 mg rituximab for six times as currently recommended regimen [9-11]. Swelling of the SMGs diminished slightly, and there was no metastatic spread. PGs and LNs showed no remarkably change on all images, whereas SMGs had ill-defined borders of nodal hypoechoic areas (Figure 3). Laboratory findings after treatment still revealed high concentrations of serum IgG4 (195 mg/dl) and sIL-2R (752.0 U/ml) (Table 1).
Figure 3

Imaging findings after treatment. (A) FDG-PET indicating unchanged abnormal multiple accumulations in the SMGs (white arrowheads) and in several systemic lymph nodes (black arrowheads). (B) CT findings indicating swelling of the PGs (white arrowheads), SMGs (white arrowheads), and generalized lymph nodes (LNs) (white arrows). (C) Sonographic images indicating vaguely-outlined hypoechoic areas in the SMGs.

Imaging findings after treatment. (A) FDG-PET indicating unchanged abnormal multiple accumulations in the SMGs (white arrowheads) and in several systemic lymph nodes (black arrowheads). (B) CT findings indicating swelling of the PGs (white arrowheads), SMGs (white arrowheads), and generalized lymph nodes (LNs) (white arrows). (C) Sonographic images indicating vaguely-outlined hypoechoic areas in the SMGs.

Conclusions

IgG4-DS is now recognized as a new emerging disorder, characterized by high serum IgG4, marked infiltration of IgG4-positive plasma cells and severe fibrosis with hyperplastic ectopic germinal centers in lacrimal and salivary glands. We recently proposed ‘Comprehensive diagnostic criteria for IgG4-RD’ [12]. IgG4-RD can be diagnosed using these comprehensive diagnostic criteria combined with organ-specific criteria. If a diagnosis of IgG4-DS is probable or possible based on these criteria, it can be confirmed according to the ‘Diagnostic criteria for IgG4-related Mikulicz’s disease’ approved by the Japanese Society for Sjögren’s syndrome in 2008, which include the following items: (i) persistent (longer than 3 months) symmetrical swelling of more than two lacrimal and major salivary glands, (ii) raised serum levels of IgG4 (>135 mg/dl), and (iii) infiltration of IgG4-positive plasma cells in the tissue (IgG4-positive plasma cells/IgG-positive plasma cells >0.4) by immunostaining. For a positive IgG4-DS diagnosis, any two of these three criteria must be fulfilled, including item (i). The present case met criteria (i) and (ii), and IgG4-DS was therefore strongly suspected. However, biopsy of the local lesion is recommended for differential diagnosis from other disorders, including sarcoidosis, Castleman’s disease, Wegener’s granulomatosis, lymphoma, and cancer. We therefore performed the cervical lymph node and SMG biopsies, resulting in a definitive diagnosis of MZL. These results suggest that biopsy of the swollen lesion is essential for a definitive diagnosis of IgG4-DS. Moreover, we have commonly performed incisional open biopsies of swollen SMGs under local anesthesia, with no complications including facial palsy, sialoceles, or wound infections. Open biopsy is thus a relatively low-invasive procedure and useful for the definitive diagnosis of IgG4-DS [13]. Isabel et al. [14] reported IgG4 expression in MZLs of various primary sites. According to their paper, 19 out of 49 (38.8%) cutaneous MZLs were positive for IgG4 expression, while only 1 out of 120 (0.8%) other MZLs were positive, especially all of 20 salivary gland MZLs showed no IgG4 expression. Therefore, salivary gland MZL positive for IgG4 as in this case is very rare. Several studies have reported IgG4-associated conditions in parts of malignant lymphoma of the ocular adnexal and lymph nodes [15]. However, IgG4-positive cells were non-neoplastic, and this IgG4-related chronic inflammation is thought to be a background for the development of malignant lymphoma [16,17]. In contrast, IgG4-producing lymphoma (non-associated IgG4-RD) also exists [18], in which the IgG4-producing cells are neoplastic and monoclonal rearrangement bands can be observed by Southern blot hybridization. Single-agent therapy of rituximab is not effective for MZL but for IgG4-RD [19]. In this case, the clinical findings, images, and laboratory examinations showed no remarkably improvement after treatment for rituximab for six times. His serum IgG4 concentration levels remained high and swelling of salivary glands was nearly unchanged, which indicated that this case might be IgG4-producing MZL but not on a background of IgG4-related chronic inflammation. Unfortunately, we were unable to confirm a strong infiltration of IgG4-positive cells in the biopsy specimens, and more case reports and further examinations are required to clarify the clinicopathological features of IgG4-RD.

Consent

Written informed consent was obtained from the patient for the publication of this report and any accompanying images.
  19 in total

1.  Ocular adnexal IgG4-producing mucosa-associated lymphoid tissue lymphoma mimicking IgG4-related disease.

Authors:  Yasuharu Sato; Koh-Ichi Ohshima; Katsuyoshi Takata; Xingang Huang; Wei Cui; Kyotaro Ohno; Tadashi Yoshino
Journal:  J Clin Exp Hematop       Date:  2012

Review 2.  Clinical and pathological characteristics of Mikulicz's disease (IgG4-related plasmacytic exocrinopathy).

Authors:  Motohisa Yamamoto; Hiroki Takahashi; Susumu Sugai; Kohzoh Imai
Journal:  Autoimmun Rev       Date:  2004-11-17       Impact factor: 9.754

3.  Clinical and pathological differences between Mikulicz's disease and Sjögren's syndrome.

Authors:  M Yamamoto; S Harada; M Ohara; C Suzuki; Y Naishiro; H Yamamoto; H Takahashi; K Imai
Journal:  Rheumatology (Oxford)       Date:  2004-10-27       Impact factor: 7.580

4.  High serum IgG4 concentrations in patients with sclerosing pancreatitis.

Authors:  H Hamano; S Kawa; A Horiuchi; H Unno; N Furuya; T Akamatsu; M Fukushima; T Nikaido; K Nakayama; N Usuda; K Kiyosawa
Journal:  N Engl J Med       Date:  2001-03-08       Impact factor: 91.245

5.  Cholangiography can discriminate sclerosing cholangitis with autoimmune pancreatitis from primary sclerosing cholangitis.

Authors:  Takahiro Nakazawa; Hirotaka Ohara; Hitoshi Sano; Shigeru Aoki; Shinya Kobayashi; Tetsu Okamoto; Hideto Imai; Tomoyuki Nomura; Takashi Joh; Makoto Itoh
Journal:  Gastrointest Endosc       Date:  2004-12       Impact factor: 9.427

6.  Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease.

Authors:  Arezou Khosroshahi; Donald B Bloch; Vikram Deshpande; John H Stone
Journal:  Arthritis Rheum       Date:  2010-06

7.  Treatment of splenic marginal zone lymphoma with rituximab monotherapy: progress report and comparison with splenectomy.

Authors:  Christina Kalpadakis; Gerassimos A Pangalis; Maria K Angelopoulou; Sotirios Sachanas; Flora N Kontopidou; Xanthi Yiakoumis; Stella I Kokoris; Evagelia M Dimitriadou; Maria N Dimopoulou; Maria Moschogiannis; Penelope Korkolopoulou; Marie-Christine Kyrtsonis; Marina P Siakantaris; Theodora Papadaki; Panayiotis Tsaftaridis; Eleni Plata; Helen E Papadaki; Theodoros P Vassilakopoulos
Journal:  Oncologist       Date:  2013-01-23

8.  Primary cutaneous marginal zone lymphomas with plasmacytic differentiation show frequent IgG4 expression.

Authors:  Isabel Brenner; Sabine Roth; Bernhard Puppe; Marion Wobser; Andreas Rosenwald; Eva Geissinger
Journal:  Mod Pathol       Date:  2013-06-14       Impact factor: 7.842

9.  Rituximab monotherapy is highly effective in splenic marginal zone lymphoma.

Authors:  C Kalpadakis; G A Pangalis; M N Dimopoulou; T P Vassilakopoulos; M-C Kyrtsonis; P Korkolopoulou; F N Kontopidou; M P Siakantaris; E M Dimitriadou; S I Kokoris; P Tsaftaridis; E Plata; M K Angelopoulou
Journal:  Hematol Oncol       Date:  2007-09       Impact factor: 5.271

10.  Acute tubulointerstitial nephritis associated with autoimmune-related pancreatitis.

Authors:  Yoko Uchiyama-Tanaka; Yasukiyo Mori; Taiko Kimura; Kazuhiro Sonomura; Shigeo Umemura; Noriko Kishimoto; Atsuko Nose; Toshiko Tokoro; Yasuaki Kijima; Hideki Yamahara; Toshiko Nagata; Hiroya Masaki; Yukihisa Umeda; Kazuichi Okazaki; Toshiji Iwasaka
Journal:  Am J Kidney Dis       Date:  2004-03       Impact factor: 8.860

View more
  7 in total

1.  IgG4-related mastitis, a rare disease, can radiologically and histologically mimic malignancy.

Authors:  Rin Yamada; Shin-ichiro Horiguchi; Toshinari Yamashita; Terumi Kamisawa
Journal:  BMJ Case Rep       Date:  2016-03-23

2.  Effectiveness of imaging modalities for screening IgG4-related dacryoadenitis and sialadenitis (Mikulicz's disease) and for differentiating it from Sjögren's syndrome (SS), with an emphasis on sonography.

Authors:  Mayumi Shimizu; Kazutoshi Okamura; Yoshitaka Kise; Yohei Takeshita; Hiroko Furuhashi; Warangkana Weerawanich; Masafumi Moriyama; Yukiko Ohyama; Sachiko Furukawa; Seiji Nakamura; Kazunori Yoshiura
Journal:  Arthritis Res Ther       Date:  2015-08-23       Impact factor: 5.156

3.  A case of mantle cell lymphoma presenting as IgG4-related dacryoadenitis and sialoadenitis, so-called Mikulicz's disease.

Authors:  Yoshikazu Hayashi; Masafumi Moriyama; Takashi Maehara; Yuichi Goto; Shintaro Kawano; Miho Ohta; Akihiko Tanaka; Sachiko Furukawa; Jun-Nosuke Hayashida; Tamotsu Kiyoshima; Mayumi Shimizu; Toru Chikui; Seiji Nakamura
Journal:  World J Surg Oncol       Date:  2015-07-25       Impact factor: 2.754

4.  Genes and pathways associated with the occurrence of malignancy in benign lymphoepithelial lesions.

Authors:  Yao Mawulikplimi Adzavon; Pengxiang Zhao; Xin Zhang; Mengyu Liu; Baobei Lv; Linqi Yang; Xujuan Zhang; Fei Xie; Mingzi Zhang; Jianmin Ma; Xuemei Ma
Journal:  Mol Med Rep       Date:  2017-11-24       Impact factor: 2.952

5.  The variety of clinical presentations in IgG4-related disease in Rheumatology.

Authors:  Agata Sebastian; Maciej Sebastian; Maria Misterska-Skóra; Piotr Donizy; Agnieszka Hałoń; Arkadiusz Chlebicki; Artur Lipiński; Piotr Wiland
Journal:  Rheumatol Int       Date:  2017-08-30       Impact factor: 2.631

6.  IgG4 expression in cutaneous marginal zone lymphoma with plasmacytic differentiation and localized amyloid deposition: A useful clue to cutaneous origin.

Authors:  Julia L Accetta; Melissa M Helm; Paul Wirth; Mihai Merzianu
Journal:  JAAD Case Rep       Date:  2018-10-03

7.  Macrophage migration inhibitory factor contributes to the pathogenesis of benign lymphoepithelial lesion of the lacrimal gland.

Authors:  Yao Mawulikplimi Adzavon; Pengxiang Zhao; Jianmin Ma; Xujuan Zhang; Xin Zhang; Mingzi Zhang; Mengyu Liu; Limin Wang; Danying Chen; Tarekegn Gebreyesus Abisso; Baobei Lv; Lei Wang; Fei Xie; Xuemei Ma
Journal:  Cell Commun Signal       Date:  2018-10-22       Impact factor: 5.712

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.